Radiolabeled compounds (radiochemical purity >97%) were supplied by American Radiolabeled Chemicals, St. Louis, MO, USA (3H-caffeine with 2.22 TBq mmol−1), Perkin–Elmer (14C- and 3H-testosterone with 2.1 GBq mmol−1 and 6.3 TBq mmol−1, respectively, 14C-caffeine with 1.89 GBq mmol−1 and 3H-mannitol with 455.6 GBq mmol−1, 3H-Water with 37 MBq ml−1) or by AH Marks and Co (14C-MCPA with 1.88 GBq mmol−1 and 14C-MCPA-2EHE with 1.02 GBq mmol−1). The radioactive isotopes are generally located at stable positions of

the molecule: 14C in the A ring of the steroid testosterone, http://www.selleckchem.com/products/bgj398-nvp-bgj398.html in phenyl ring of MCPA and MCPA-EHE and in the methyl group at N-1 of caffeine; 3H generally at non-acidic groups (testosterone at positions C-1, C-2, C-6, C-7, C-16 and C-17, mannitol at C-1 and caffeine in methyl group at N-1). Split-thickness (450 ± 100 μm) and full-thickness (1000 ± 200 μm) female human skin samples from abdominal surgery were purchased from Biopredic, France. Rat skin was excised from the back of eight-week-old female Crl:WI (Han) rats (Charles River, Germany) after sedation with isoflurane and exsanguination. Split-thickness

skin (450 ± 100 μm) was generated with a Dermatome GA 643 (Aesculap, Germany) after hair trimming. For a special investigation various grades of barrier impairment were induced by stressing excised rat skin with chemical or mechanical selleck kinase inhibitor treatment in advance of experiments using 14C-MCPA as the test substance. Such pretreatment scenarios comprises combinations of water application or application of MCPA formulation (see Table 1) with or without MCPA and one or three washing steps with cotton swabs and 0.7% aqueous Texapon® N70 solution over three consecutive days. The individual treatments are given in Thalidomide Table 2. Experiments 1–3 comprise the ‘undamaged’ skin and experiments 4–9 the ‘damaged’ skin. StrataTest® (100–115 μm) purchased from Stratatech Corporation,

USA, is a reconstructed human skin model which was added in the current setup as a human skin system with generally lower barrier functionality. All studies were conducted following the OECD-Guideline 428 and the corresponding technical guidance document 28 (OECD, 2004a and OECD, 2004b). Five skin samples per run, derived from at least two different donors, were mounted on Franz type diffusion cells with a surface area of 1 cm2 and receptor volume of 4 ml (Laboratory Glass Apparatus Inc., USA). The water jacket around the receptor compartment was maintained using a water thermostat pump (Thermo Haake, Germany) at a temperature of 32 °C. A finite dose was applied to the surface of the skin under occlusive (Parafilm “M”®, Pechiney Plastic Packaging, USA) or semi-occlusive (Fixomull®, BSN medical, Germany) conditions.